Clinical Trial Update: Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating once-daily versus twice-daily insulin glargine for managing pregestational diabetes in pregnancy. The study is currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus During Pregnancy
• Diabetes Mellitus Pregestational

Drugs mentioned

• Insulin Glargine (insulin glargine)

Snippet

Sponsor: Eastern Virginia Medical School | Conditions: Pregestational Diabetes, Pregnancy | Phase 4 | Status: NOT_YET_RECRUITING